Pharmaceuticals , Inc. (Nasdaq:ALNY), a leading RNAi therapeutics
company, announced today its pipeline growth strategy for development
and commercialization of RNAi therapeutics across three Strategic
Therapeutic Areas (STArs): Genetic Medicines, Cardio-metabolic Disease,
and Hepatic Infectious Disease.
By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- European stocks sank Friday as energy shares continued to take blows from the oil-price slide, with the Stoxx Europe 600 on track for its sharpest weekly decline since 2012.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.